The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 28, 2023

Filed:

Aug. 30, 2017
Applicants:

Taro Pharmaceutical Industries Ltd., Haifa Bay, IL;

Yissum Research Development Company of the Hebrew University of Jerusalem Ltd., Jerusalem, IL;

Inventors:

Wahid Khan, Hyderabad, IN;

Helena Shifrin, Rehovot, IL;

Ron Schlinger, Tel-Aviv, IL;

Avi Avramoff, Haifa, IL;

Abraham Jacob Domb, Jerusalem, IL;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/55 (2006.01); A61P 17/06 (2006.01); A61K 9/00 (2006.01); A61K 9/06 (2006.01); A61K 9/12 (2006.01); A61K 9/70 (2006.01); A61K 45/06 (2006.01); A61K 47/06 (2006.01); A61K 47/10 (2017.01); A61K 47/12 (2006.01); A61K 47/32 (2006.01);
U.S. Cl.
CPC ...
A61K 31/55 (2013.01); A61K 9/0014 (2013.01); A61K 9/06 (2013.01); A61K 9/122 (2013.01); A61K 9/7038 (2013.01); A61K 45/06 (2013.01); A61K 47/06 (2013.01); A61K 47/10 (2013.01); A61K 47/12 (2013.01); A61K 47/32 (2013.01); A61P 17/06 (2018.01);
Abstract

Embodiments of stable topical compositions for administering fenoldopam (compound (I) or a pharmaceutically acceptable salt or solvate thereof are disclosed for immediate or continued slow release administration, over prolonged periods of time with safe minimal systemic exposure of fenoldopam (reducing the risk for lowering blood pressure). The compositions include those compositions that increase the stability and skin absorption of the drug, particularly anhydrous semi-solid compositions and creams. This is accomplished by incorporating fenoldopam in soluble or dispersed form into semi-solid compositions like ointments or anhydrous gels that are not irritative. Embodiments of methods for using the topical compositions in the treatment of dermatological disorders including psoriasis, alopecia atopic dermatitis and vitiligo are disclosed.


Find Patent Forward Citations

Loading…